Peter Colbourne

Peter Colbourne has a diverse work experience spanning several companies and roles. Peter currently works as a Senior Business Development Manager at WuXi Advanced Therapies since August 2022. Prior to that, Peter worked as a Managing Director at ConcentRx Consulting since July 2007.

Peter also served as a Business Development Consultant at Medicover Integrated Clinical Services, focusing on expanding capabilities in precision medicine and global clinical research from January 2021 to August 2021. As a Strategic Business Consultant, Peter worked at Genome Explorations Inc from July 2019 to November 2020 and at SpeciCare from March 2020 to September 2020.

Peter has also held positions at LabConnect, where they worked as a Strategic Business Consultant from March 2017 to June 2020, and as a Business Development Director from May 2010 to March 2017. Peter served as a Senior Director of Business Development at CEQAL Inc from November 2019 to April 2020.

Earlier in their career, Peter held senior leadership positions at Clinical Systems Ltd. from March 2008 to April 2010, Integrated Research Inc. from March 2008 to July 2009, and SYMFO, Inc. from March 2008 to July 2009.

Peter Colbourne attended Memorial University of Newfoundland from 1979 to 1986, where they obtained a B.Sc. degree in Biochemistry. Additionally, they attended Dalhousie University from 1981 to 1984, where they also earned a B.Sc. degree in Biochemistry.